Discontinuation of Primary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral Therapy

Abstract

Stopping primary prophylaxis against P. carinii pneumonia appears to be safe in HIV-infected patients who are receiving combination antiretroviral treatment and who have had a sustained increase in their CD4 counts to at least 200 cells per cubic millimeter and to at least 14 percent of total lymphocytes.